Atlas Trials

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Clinical trial NCT05322850 · SUSPENDED

Trial details

NCT number
NCT05322850
Sponsor
University of Florida
Status
SUSPENDED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute LeukemiaAcute Undifferentiated LeukemiaChronic Myeloid Leukemia in Myeloid Blast CrisisChronic Myeloid Leukemia in Lymphoid Blast Crisis (Diagnosis)Chronic Myeloid Leukemia - Accelerated Phase
Start date
2022-08-16
Primary completion
2026-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.